Impact of Lipoprotein(a) on Long-Term (Mean 6.2 Years) Outcomes in Patients with Three-Vessel Coronary Artery Disease

The aim of the cohort study was to investigate the relationship between plasma lipoprotein(a) [Lp(a)] and long-term clinical outcomes in patients with 3-vessel disease (TVD) after the following treatment strategies, including medical therapy (MT) alone, percutaneous coronary intervention(PCI), and coronary artery bypass grafting (CABG). A total of 6,175 consecutive patients with angiographically confirmed TVD and available baseline Lp(a) data were included in this study. Based on the median level of Lp(a) at admission, the patient was divided into two sub-groups.

Source: The American Journal of Cardiology - November 6, 2019 Category: Cardiology Authors: Na Xu, Lin Jiang, Lianjun Xu, Jian Tian, Ce Zhang, Xueyan Zhao, Xinxing Feng, Dong Wang, Yin Zhang, Kai Sun, Jingjing Xu, Ru Liu, Bo Xu, Wei Zhao, Rutai Hui, Runlin Gao, Zhan Gao, Lei Song, Jinqing Yuan Source Type: research